Bharat Biotech submitted the data of Phase 3 to the Drug Controller General of India on June 19. Covaxin, developed by Bharat Biotech, is being administered in the country since January this year.
Indian vaccine manufacturer, Bharat Biotech, submitted the data of the phase 3 trial to the Drug Controller General of India on June 19.
The Subject Expert Committee will take it up for discussion on June 22.
Hyderabad-based Bharat Biotech has indigenously developed a vaccine for Covid-19, Covaxin. Together with Serum Institute manufactured Covishield, it is being administered on a large scale in the country.
Bharat Biotech has also applied to the WHO for emergency use authorization for using Covaxin in other countries.
The company had claimed an interim efficacy of 81% in March this year.
India is the largest manufacturer of vaccines in the world. The country has an immense responsibility of not only vaccinating its population but the world.
#RSSIsHere Ready For Selfless Service | RSS India | Rastriya Sewa | Latest 2021 | New | Trending Crisis comes uncalled, but sons of the soil, are the one who hold the nation first irrespective of the situation. The Rashtriya Swayamsevak Sangh has steadfastly performed its duties selflessly. The sangh is also preparing itself for the third wave of Corona and work can be seen in every part of the country. Download Organiser Mobile App: https://play.google.com/store/apps/details?id=org.organiser...
Adnan alias Ismail alias Lamboo was closely related to Jaish founder Maulana Masood Azhar and had entered India in 2018. In a big success for the security forces in Kashmir, Jaish-e-Mohammed terrorist Adnan alias Ismail alias Lamboo was killed in an encounter today (July 31) morning. In a post, the Indian Army said, “Op Hangalmarg, #Pulwama. A Joint Op was launched today morning at Hangalmarg in Dachigam forest, Pulwama based on @JmuKmrPolice inputs ...